841 related articles for article (PubMed ID: 19617747)
41. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
42. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
43. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
44. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.
Bilimoria KY; Bentrem DJ; Rock CE; Stewart AK; Ko CY; Halverson A
Dis Colon Rectum; 2009 Apr; 52(4):624-31. PubMed ID: 19404066
[TBL] [Abstract][Full Text] [Related]
45. Conservative treatment for carcinoma of the anus--a report of 35 patients.
Serkies K; Bednaruk-Mlynski E; Dziadziuszko R; Jassem J
Neoplasma; 2003; 50(2):152-8. PubMed ID: 12740652
[TBL] [Abstract][Full Text] [Related]
46. Surgical therapy for anorectal melanoma.
Bullard KM; Tuttle TM; Rothenberger DA; Madoff RD; Baxter NN; Finne CO; Spencer MP
J Am Coll Surg; 2003 Feb; 196(2):206-11. PubMed ID: 12595048
[TBL] [Abstract][Full Text] [Related]
47. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
48. Anal carcinoma: a 14 year experience.
Gallén M; Pla J; Miguel A; Ibeas R; Carles J; Fabregat X
Rev Esp Enferm Dig; 1997 Jan; 89(1):23-8. PubMed ID: 9055585
[TBL] [Abstract][Full Text] [Related]
49. Anal canal cancer: a population-based reappraisal.
Maggard MA; Beanes SR; Ko CY
Dis Colon Rectum; 2003 Nov; 46(11):1517-23; discussion 1523-4; author reply 1524. PubMed ID: 14605572
[TBL] [Abstract][Full Text] [Related]
50. Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy.
Kelsey CR; Nelson JW; Willett CG; Chino JP; Clough RW; Bendell JC; Tyler DS; Hurwitz HI; Morse MA; Clary BM; Pappas TN; Czito BG
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1436-41. PubMed ID: 17689032
[TBL] [Abstract][Full Text] [Related]
51. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.
Blazy A; Hennequin C; Gornet JM; Furco A; Gérard L; Lémann M; Maylin C
Dis Colon Rectum; 2005 Jun; 48(6):1176-81. PubMed ID: 15906137
[TBL] [Abstract][Full Text] [Related]
52. 50-year appraisal of gastrinoma: recommendations for staging and treatment.
Ellison EC; Sparks J; Verducci JS; Johnson JA; Muscarella P; Bloomston M; Melvin WS
J Am Coll Surg; 2006 Jun; 202(6):897-905. PubMed ID: 16735203
[TBL] [Abstract][Full Text] [Related]
53. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
[TBL] [Abstract][Full Text] [Related]
54. Surgical management and outcome in primary adenocarcinoma of the small bowel.
Agrawal S; McCarron EC; Gibbs JF; Nava HR; Wilding GE; Rajput A
Ann Surg Oncol; 2007 Aug; 14(8):2263-9. PubMed ID: 17549572
[TBL] [Abstract][Full Text] [Related]
55. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors and clinicopathologic characteristics of invasive adenocarcinoma of the uterine cervix.
Chargui R; Damak T; Khomsi F; Ben Hassouna J; Chaieb W; Hechiche M; Gamoudi A; Boussen H; Benna F; Rahal K
Am J Obstet Gynecol; 2006 Jan; 194(1):43-8. PubMed ID: 16389008
[TBL] [Abstract][Full Text] [Related]
57. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
[TBL] [Abstract][Full Text] [Related]
58. Paranasal sinus malignancies: an 18-year single institution experience.
Myers LL; Nussenbaum B; Bradford CR; Teknos TN; Esclamado RM; Wolf GT
Laryngoscope; 2002 Nov; 112(11):1964-9. PubMed ID: 12439163
[TBL] [Abstract][Full Text] [Related]
59. Treatment and outcomes in adult patients with primary cardiac sarcoma: the British Columbia Cancer Agency experience.
Truong PT; Jones SO; Martens B; Alexander C; Paquette M; Joe H; Hart J; Allan SJ
Ann Surg Oncol; 2009 Dec; 16(12):3358-65. PubMed ID: 19830494
[TBL] [Abstract][Full Text] [Related]
60. Management of carcinoma of the gallbladder: a single-institution experience in 16 years.
Chan SY; Poon RT; Lo CM; Ng KK; Fan ST
J Surg Oncol; 2008 Feb; 97(2):156-64. PubMed ID: 18050290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
